Bartelink, W.

virus fluenza vaccine fluenza virus antigen antibody titer group response animal sna 4 assay neuraminidase fluenza viruses adjuvant immunity iscom matrix m vaccination immunization infection antigenic protein expression protection strain vaccinated multimeric puri fied virus replication activity hemagglutinin virus titers effect challenge weight glycoprotein johansson hi titers sna 4 antigens pandemic adjuvanted kilbourne 100 ␮ l 3.75 study sequence combination virol signi 3ϩsna control iscom antibody responses /nl virus culture domain /new jersey /8/76 fluenza virus vaccines sample inoculation panel matrix result level fluenza virus neuraminidase aa 75 serum throat hi assay sna 4. netherland system speci fluenza vaccines replication detection limit /netherland nonadjuvanted 2009. reduction